Additional possible targets of CX3CL1 signaling in AD have been suggested: Cho et al. (2011) demonstrated that hAPP/cx3cr1-/- mice have exacerbated neuronal and cognitive function defects and increased inflammatory responses in comparison with hAPP/cx3cr1+/+ mice. This evidence concerns the gene CX3CL1 and Alzheimer disease.